Summary
We previously demonstrated maternal monoallelic expression of the Wilms tumor suppressor gene,WT1, in about half of pre-term placental villus and fetal brain tissues examined. There were two alternative explanations for this pattern of theWT1 expression,i.e., an imprinting polymorphismvs. a developmental stage-dependent switching from monoallelic to biallelic expression of the gene. To investigate these possibilities, we examinedWT1 expression in a larger number of villus samples (46 samples) with gestational ages ranging from 4 to 21 weeks, using reverse transcriptase-based polymerase chain reaction (RT-PCR) to amplify the sequences for polymorphic sites in the 3′-untranslated region (UTR) ofWT1. Maternal monoallelic expression was observed in 7 (39%) of 18 samples informative for the polymorphism, while the expression of the remaining 11 samples was biallelic. In addition, there was no correlation between expression patterns and gestational ages of the samples. The results indicate that the pattern of expression (monoallelicvs. biallelic) is polymorphic. The expression patterns were also studied in five different organs from a 21-week-old fetus, showing monoallelic expression only in the placenta and biallelic expression in other organs (heart, lung, liver and intestine). The finding supports the tissue specificity of theWT1 monoallelic expression.
Similar content being viewed by others
Article PDF
References
Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yegar H, Lewis WH, Jones C, Houseman DE (1990): Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell60: 509–520
DeChiara TM, Robertson EJ, Efstratiadis A (1991): Parental imprinting of the mouse insulin-like growth factor II gene. Cell64: 849–859
Drumond IA, Madden SL, Rohwew-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III (1992): Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science257: 674–677
Gessler M, Konig A, Bruns GAP (1992): The genomic organization and expression of the WT1 gene. Genomics12: 807–813
Giannoukakis N, Deal C, Paquette C, Goodyer CG, Polychronakos C (1993) Parental genomic imprinting of the human IGF2 gene. Nature Genet4: 98–101
Hatada I, Inazawa J, Abe T, Nakayama M, Kaneko Y, Jinno Y, Niikawa N, Ohashi H, Fukushima Y, Iida K, Yutani C, Takahashi S, Chiba Y, Ohishi S, Mukai T (1996): Genomic imprinting of human p57KIP2 and its reduced expression in Wilms’ tumors. Hum Mol Genet5: 783–788
Hoban PR, Kesley AM (1990):HinfI polymorphism within the 3′ untranslated region of the candidate Wilms tumor gene. Nucleic Acids Res19: 1164
Jinno Y, Yun K, Nishiwaki K, Kubota T, Ogawa O, Reeve AE, Niikawa N (1994): Mosaic and polymorphic imprinting of the WT1 gene in humans. Nature Genet6: 305–309
Jinno Y, Ikeda Y, Yun K, Maw M, Masuzaki H, Fukuda H, Inuzuka K, Fujishita A, Ohtani Y, Okimoto T, Ishimaru T, Niikawa N (1995): Establishment of functional imprinting of theH19 gene in human developing placentae. Nature Genet10: 318–324
Kalscheuer VM, Mariman EC, Schepens MT, Rehder H, Ropers HH (1993): The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nature Genet5: 74–78
Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher FJ III (1991): Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science253: 1550–1553
Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE (1993a): Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms’ tumor. Nature362: 749–751
Ogawa O, Becroft DM, Morison IM, Eccles MR, Skeen JE, Mauger DC, Reeve AE (1993b): Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms’ tumor and gigantism. Nature Genet5: 408–412
Ohlsson R, Nyström A, Pfeiffer-Ohlsson S, Töhönen V, Hedborg F, Schofield P, Flam F, Ekström TJ (1993): IGF2 is paternally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nature Genet4: 94–97
Özçelik T, Leff S, Robinson W, Donlon T, Lalande M, Sanjines E, Schinzel A, Francke U (1993): Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region. Nature Genet2: 265–269
Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP (1993): Relaxation of imprinted genes in human cancer. Nature362: 747–748
Rauscher FJ III (1993): The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J7: 896–903
Surani MA (1993): Silence of the genes. Nature366: 302–303
Sutcliffe J, Nakao M, Christian S, Örstavik KH, Tommerup N, Ledbetter DH, Beaudet AL (1994): Deletions of a differentially methylated CpG island at theSNRPN gene define a putative imprinting control region. Nature Genet8: 52–58
Suzuki H, Ueda R, Takahashi T, Takahashi T (1994): Altered imprinting in lung cancer. Nature Genet6: 332–333
Vu TH, Hoffman AR (1994): Promotor-specific imprinting of the human insulin-like growth factor-II gene. Nature371: 714–717
Wevrick R, Kerns JA, Francke U (1994): Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum Mol Genet3: 1877–1882
Weksberg R, Shen DR, Fei YL, Song QL, Squire J (1993): Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet5: 143–149
Xu Y, Goodyer CG, Deal C, Polychronakos C (1993): Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem Biophys Res Commun197: 747–754
Zang Y, Tycko B (1992): Monoallelic expression of the human H19 gene. Nature Genet1: 40–44
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishiwaki, K., Niikawa, N. & Ishikawa, M. Polymorphic and tissue-specific imprinting of the human wilms tumor gene,WT1 . Jap J Human Genet 42, 205–211 (1997). https://doi.org/10.1007/BF02766923
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02766923